Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy

Autor: Alvise Sernicola, Emanuele Amore, Giuseppe Rizzuto, Alessandra Rallo, Maria Elisabetta Greco, Chiara Battilotti, Francesca Svara, Giulia Azzella, Steven Paul Nisticò, Annunziata Dattola, Camilla Chello, Giovanni Pellacani, Teresa Grieco
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Nutrients, Vol 16, Iss 16, p 2797 (2024)
Druh dokumentu: article
ISSN: 2072-6643
DOI: 10.3390/nu16162797
Popis: IgE-mediated food allergy is characterized immunologically by a type 1 immune response triggered upon exposure to specific foods and clinically by a broad range of manifestations and variable severity. Our understanding of food allergy within the allergic march of atopic dermatitis (AD) is still incomplete despite the related risk of unpredictable and potentially severe associated reactions such as anaphylactic shock. The aim of this pilot study was to investigate the effects of dupilumab, an IL-4/IL-13 monoclonal antibody approved for AD, on the allergic sensitization profile of patients with AD and type 1 hypersensitivity-related comorbidities, including oral allergy syndrome, anaphylaxis, and gastrointestinal disorders. We conducted an observational pilot study with a longitudinal prospective design, enrolling 20 patients eligible for treatment with dupilumab. Laboratory exams for total serum IgE, specific IgE, and molecular allergen components were performed at baseline and after 16 weeks of therapy. Our results demonstrate a statistically significant decrease in molecular components, specific IgE for trophoallergens, and specific IgE for aeroallergens following treatment with dupilumab. We suggest that modulating type 2 immunity may decrease IgE-mediated responses assessed with laboratory exams and therefore could minimize allergic symptoms in polysensitized patients. Upcoming results of randomized controlled trials investigating dupilumab in food allergy are highly anticipated to confirm its potential effect in the treatment of IgE-mediated food allergies.
Databáze: Directory of Open Access Journals